Belvedere Trading LLC Sc Pharmaceuticals Inc. Transaction History

Belvedere Trading LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$4.48 - $6.52 $530,938 - $772,704	-118,513 Reduced 49.54%	120,706 $661,000
Q2 2022 Jul 21, 2022	BUY	$4.3 - $6.48 $336,849 - $507,623	78,337 Added 48.69%	239,219 $1.27 Million
Q1 2022 Apr 20, 2022	BUY	$3.9 - $6.11 $627,439 - $982,989	160,882 New	160,882 $822,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $90.2M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.